ICD-10-CM Billable Code

B50.0

Plasmodium falciparum malaria with cerebral complications

Clinical Classification Guidelines

Inclusion Terms

  • Cerebral malaria NOS

Medical Intelligence & Overview

Plasmodium falciparum malaria with cerebral complications is a severe form of malaria caused by the malaria parasite Plasmodium falciparum. It primarily affects the brain, leading to serious neurological symptoms. This condition requires timely medical attention to manage symptoms and prevent serious outcomes. The term 'cerebral malaria NOS' indicates that the complication involves neurological issues specific to the brain but does not specify a particular type or cause.

Causes & Symptoms

Clinical Causes: Infection with Plasmodium falciparum, the most dangerous malaria parasite species. Transmission of the parasite through the bite of infected female Anopheles mosquitoes. Inadequate prevention measures or failure to seek prompt treatment after exposure, increasing the risk of severe malaria. Pre-existing health conditions or weakened immune system, which can worsen the progression. Travel to or residence in regions where malaria is endemic, such as parts of Africa, Southeast Asia, and parts of South America.

Key Symptoms: High fever that often spikes regularly Severe headache and confusion Difficulty concentrating or disorientation Seizures or convulsions Unconsciousness or coma in advanced cases Nausea and vomiting Muscle weakness or paralysis Altered mental state and agitation

Diagnostic & Treatment

Diagnosis Path: Diagnosing cerebral malaria involves a combination of clinical assessments and laboratory tests. Key steps include: - Blood smear microscopy to detect Plasmodium falciparum parasites - Rapid diagnostic tests (RDTs) designed for malaria detection - Neurological examination to assess mental status and neurological deficits - Additional tests such as brain imaging may be used to rule out other causes of neurological symptoms, though diagnosis primarily relies on blood tests and clinical presentation. Early diagnosis is crucial to initiate effective treatment and prevent lasting brain damage or death.

Treatment Protocols: Managing cerebral malaria typically involves prompt and aggressive treatment to eliminate the parasite and address neurological complications. Common approaches include: - Antimalarial medications, such as artesunate or quinine, administered intravenously or orally - Supportive care to stabilize vital functions, including hydration and correction of electrolyte imbalances - Management of seizures with anticonvulsant drugs - Monitoring and addressing signs of increased intracranial pressure - Intensive care support for unconscious or severely affected patients Treatment duration depends on disease severity and response to therapy. Early intervention is vital to improve outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B50.0 a billable ICD-10 code?
Yes, B50.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B50.0?
Clinical documentation must specify the nature of Plasmodium falciparum malaria with cerebral complications and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

cerebral falciparum complications plasmodium malaria